[1]
Murase, J.E. , Munera-Campos, M. , Hong, H.C.- ho ., Taieb, A. , Chung, W.-H. , Reck Atwater, A., Rueda, M.J. , Zhong, J. , Buziqui Piruzeli, M.L. , Pau-Charles, I. and Deleuran, M. 2023. Lebrikizumab-Treated Patients With Atopic Dermatitis Had No Increase in Treatment-Emergent Adverse Events of Facial, Head, and Neck Erythema Compared to Placebo. SKIN The Journal of Cutaneous Medicine. 7, 6 (Nov. 2023), s272. DOI:https://doi.org/10.25251/skin.7.supp.272.